EP Patent

EP0231026B1 — Sustained-release dihydropyridine formulation

Assigned to Syntex USA LLC · Expires 1992-11-04 · 34y expired

What this patent protects

Patent listed against donepezil-hydrochloride.

Drugs covered by this patent

donepezil-hydrochloride (DONEPEZIL HYDROCHLORIDE)

Patent Metadata

Patent number: EP0231026B1
Jurisdiction: EP
Classification: —
Expires: 1992-11-04
Drug substance claim: No
Drug product claim: No
Assignee: Syntex USA LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.